FDA Action on Antiseptic Wash Products: What’s Next for the Industry?

Event Information
Product Format
Prerecorded Event
Presenter(s)
Conference Date
Tue, Dec 13, 2016
Length
60 minutes
Product Description

FDA Action and Future of Antiseptic Wash Products Industry

 

The FDA just banned 19 active ingredients that are used in antibacterial soaps. This major regulation will have a huge impact on this multi-million dollar industry since the FDA Rule will require companies to remove these products from the market or remove the ingredients from their products. Manufacturers will have one year to take these products off the market or reformulate them.

This presentation by expert speaker Norma Skolnik will cover the recent FDA action on antiseptic wash products and analyze the impact on the industry. You will get an understanding of why the FDA banned the 19 active ingredients in antiseptic/antibacterial soaps. Also, you’ll learn what companies can do to comply with FDA requirements for those active ingredients still allowed to remain on the market and ensure that they remain marketable in the U.S.

Session Highlights

  • FDA reasons for banning certain ingredients in antiseptic/antibacterial soap products.
  • 19 ingredients that FDA says can no longer be marketed in antiseptic soaps.
  • Ingredients for which FDA has deferred rulemaking to allow for development and submission of new safety and effectiveness data.
  • Timelines for compliance with FDA’s final rule.
  • Products not affected by the final rule and usage requirements.
  • Industry response to FDA action.

Who Should Attend

  • Regulatory managers
  • Regulatory associates
  • Marketing managers at firms that market antiseptic products
  • QA managers

Ask a question at the Q&A session following the live event and get advice unique to your situation, directly from our expert speaker.

Order Below or Call 1-866-458-2965 Today

You can also order through:
Phone

1-866-458-2965

Fax

1-919-287-2643

About Our Speaker

Norma Skolnik - FDA Regulations Expert

Norma Skolnik has over 35 years of regulatory experience working with the pharmaceutical and dietary supplement industries. She served as Director of Regulatory Affairs for the Americas for Cadbury Adams. Prior to that, she was Director of Regulatory Affairs for the Adams Division of Pfizer and Associate Director of Regulatory Affairs for the Warner-Lambert company. She also served as Director of Regulatory Affairs for Lederle Consumer Healthcare and...   More Info
More Events By The Speaker

Why AudioEducator?
  • Save money on travel.
  • Meet your specific training needs.
  • Keep learning after the event.
  • Save time training your whole staff.
Join Our Mailing List
Our Accreditation Partners
Facebook Twitter Linkedin Youtube RSS Feeds Google Plus